Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Neuroimaging, Disease, Alzheimer's Disease Neuroimaging Initiative, Medicine, Alzheimer's disease, and Biomarker.
Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials
Individuals with Alzheimer's disease and low tau burden: Characteristics and implications
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer’s disease
The POINTER Imaging baseline cohort: Associations between multimodal neuroimaging biomarkers, cardiovascular health, and cognition
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022
Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
Altered behavior, brain structure, and neurometabolites in a rat model of autism-specific maternal autoantibody exposure
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4
Traumatic brain injury and post‐traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease
Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
The trend of disruption in the functional brain network topology of Alzheimer’s disease
Plasma biomarkers predict cognitive trajectories in an ethnoracially and clinically diverse cohort: Mediation with hippocampal volume
The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
A deep learning framework identifies dimensional representations of Alzheimer’s Disease from brain structure
Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology
An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury